ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy ® (epinephrine ...

In this special edition of the Student Notebook, early-career scholars from across the APSSC community share their ...

New information to be presented on the study design and methodology of Purespring’s Phase I/IItrial of PS-002, an AAV-based therapy delivering ...

SUBSCRIBE FOR MORE VIDEOS Never miss a video . Subscribe Support ME and get SPECIAL perks JOIN my PATREON Buy me a Ko-Fi What ...

Natural Field, a leading Chinese supplier of botanical and functional ingredients, is set to release its highly anticipated Ashwagandha White Paper at the prestigious Food Technology and Application ...

IVI RMA, the world's leading reproductive medicine group, announced that joint research with Juno Genetics that utilized data from the Foundation for Embryonic Competence and RMA ...

Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated ...

Felzartamab, an investigational anti-CD38 monoclonal antibody, is a potentially differentiated therapeutic candidate with promise for a broad range of immune-mediated diseases ...

Initiated PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care ...

Preston Mason- Available November 10, 2:13pm CST- Basic Science Zone, Moderated Digital Poster 25 About Amarin Amarin is a global ... including Amarin's quarterly report on Form 10-Q for the period ...

Dose selection from Phase 2/3 Duravelo-2 trial and update on potential approval pathway expected in 1Q 2026 as company seeks feedback from multiple regulatory agencies Enhanced clinical leadership ...